KATY, TX / ACCESS Newswire / July 20, 2026 / As life science research grows more refined and diversified, antibodies are no longer mere lab tools-they have become critical determinants of research data reliability. With continuously segmented target studies and evolving experimental workflows, multifaceted research demands raise higher standards for antibody resource abundance and compatibility.
For nearly two decades, Cloud-Clone has specialized in research antibody development. We maintain full independent R&D and in-house production across the complete industrial chain: antigen design, antibody generation, rigorous quality control, and custom services. We have fully eliminated reliance on imported raw materials to achieve end-to-end domestic independent manufacturing. Backed by an extensive antibody catalog, broad target coverage, and mature multi-technology platforms, Cloud-Clone has evolved into a global benchmark for research antibody diversity, trusted by scientists worldwide as a core supplier of antibody resources.
From ELISA Kits to End-to-End Independent R&D: Cloud-Clone's 20-Year Journey of Domestic Substitution
Cloud-Clone launched its business focusing on ELISA kits, a market once dominated by international brands. We started by sourcing imported protein and antibody raw materials to manufacture kits, then resolved to independently develop native proteins and antibodies. After nearly 20 years of progress, we now operate a fully self-contained workflow from antigen design to finished antibody production.
